The Dementia Drugs Market is segmented by Indications, Drug Class, and Geography.

Dementia Drugs

 

Dementia is an application of disease that affects the functioning of the mind causing decline in memory and other thinking skills. Alzheimer's disease is the most frequent and largest type of dementia (in over 60% cases), which is observed among people aged 65 years and above. Accumulation of a protein called beta amyloid in the spaces between nerve cells as a result of genetic mutation is a major reason behind dementia. Although dementia is not treatable, symptomatic treatment is followed in most cases. Research will be carried out to produce therapies dedicated to the role of beta-amyloid in dementia.

The increasing prevalence of target disease and the growing geriatric population experiencing these diseases are expected to market the growth of the Dementia Drugs Market.The increasing burden of dementia cases is one of many major factors driving the growth of the global dementia drug market.

Alzheimer's disease is expected to cultivate at a lucrative CAGR through the forecast period. The high prevalence of the diseases is because of the growing geriatric population base along with the weak immune system. According to the World Health Organization, Alzheimer's disease is the most frequent type of dementia and may subscribe to 60-80% of cases worldwide.

The dementia drugs market is segmented by indications, drug class, and geography. By Indications, industry is segmented into Lewy Body Dementia, Parkinson's Disease Dementia, Alzheimer's Disease, Vascular Dementia, and Other Indications. By Drug Class, industry is segmented into MAO Inhibitors, Glutamate Inhibitors, and Cholinesterase Inhibitors.

Comments

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Ginseng Market Outlook, Analysis and forecast up to 2028

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19